\-\ Texto\\:\\ \ \(0\)\
\-\ as\\ above\\.\ \(7\)\
\-\ cyclophosphamide\\ \\+\\ prednisone\ \(0\)\
\-\ ct\\ chest\\,\\ lung\\ windows\\:\\ bilateral\\,\\ perihilar\\,\\ focal\\,\\ rounded\\,\\ nonconsolidative\\ noncavitated\\ opacities\\.\\ \ \(0\)\
\-\ cxr\\,\\ pa\\ \\&\\ lateral\\:\\ bilateral\\,\\ perihilar\\,\\ focal\\,\\ ill\\-defined\\,\\ strandy\\ and\\ subtle\\ rounded\\ opacities\\.\ \(0\)\
\-\ wegeners\ \(2\)\
\-\ 1\\)\\ wegeners\ \(0\)\
\-\ 2\\)\\ goodpastures\ \(0\)\
\-\ 3\\)\\ other\\ autoimmune\\ vasculitides\\ \\-\\ collagen\\ vascular\\ disease\\ category\ \(0\)\
\-\ 4\\)\\ other\\ granulomatous\\,\\ infectious\\ \\-\\ tb\\,\\ histoplasmosis\ \(0\)\
\-\ 5\\)\\ other\\ granulomatous\\,\\ noninfectious\\ \\-\\ sarcoid\\,\\ eg\ \(0\)\
\-\ high\\ serologic\\ titers\\ of\\ antineutrophil\\ cytoplasmic\\ antibody\\.\\ bronchoscopic\\ biopsy\\-proven\\ wegeners\\ granulomatosis\\.\\ patient\\ presents\\ with\\ mild\\ hemoptysis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ wegeners\\:\\ 0\\.22287672188539823\ \(0\)\
\-\ perihilar\\:\\ 0\\.11639572300825014\ \(0\)\
\-\ opacities\\:\\ 0\\.08917619194553814\ \(0\)\
\-\ nonconsolidative\\:\\ 0\\.08815518423966498\ \(0\)\
\-\ noncavitated\\:\\ 0\\.08815518423966498\ \(0\)\
\-\ bronchoscopic\\:\\ 0\\.08815518423966498\ \(0\)\
\-\ rounded\\:\\ 0\\.08420696475956813\ \(0\)\
\-\ granulomatous\\:\\ 0\\.0824834108347471\ \(0\)\
\-\ strandy\\:\\ 0\\.08122371243406554\ \(0\)\
\-\ goodpastures\\:\\ 0\\.07716906135298389\ \(0\)\
\-\ antineutrophil\\:\\ 0\\.07716906135298389\ \(0\)\
\-\ biopsy\\-proven\\:\\ 0\\.07429224062846608\ \(0\)\
\-\ serologic\\:\\ 0\\.07206080511532398\ \(0\)\
\-\ vasculitides\\:\\ 0\\.07023758954738443\ \(0\)\
\-\ noninfectious\\:\\ 0\\.06736076882286662\ \(0\)\
\-\ titers\\:\\ 0\\.06736076882286662\ \(0\)\
\-\ cytoplasmic\\:\\ 0\\.06618293846630278\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.0617646109435124\ \(0\)\
\-\ other\\:\\ 0\\.059089156461073454\ \(0\)\
\-\ antibody\\:\\ 0\\.056800242080373486\ \(0\)\
\-\ category\\:\\ 0\\.055966425990982976\ \(0\)\
\-\ \\-\\:\\ 0\\.054951853761250904\ \(0\)\
\-\ autoimmune\\:\\ 0\\.05448222593980024\ \(0\)\
\-\ histoplasmosis\\:\\ 0\\.054143210423043424\ \(0\)\
\-\ granulomatosis\\:\\ 0\\.05349782521166772\ \(0\)\
\-\ windows\\:\\ 0\\.052046005113222736\ \(0\)\
\-\ eg\\:\\ 0\\.051266389698525615\ \(0\)\
\-\ prednisone\\:\\ 0\\.05054318308272936\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.049236981258558715\ \(0\)\
\-\ focal\\:\\ 0\\.04880987208276804\ \(0\)\
\-\ collagen\\:\\ 0\\.0486427470538507\ \(0\)\
\-\ ill\\-defined\\:\\ 0\\.04826534377402224\ \(0\)\
\-\ \\+\\:\\ 0\\.04408799176702245\ \(0\)\
\-\ sarcoid\\:\\ 0\\.04384701625123184\ \(0\)\
\-\ bilateral\\:\\ 0\\.04147635458628888\ \(0\)\
\-\ tb\\:\\ 0\\.041150380581740816\ \(0\)\
\-\ subtle\\:\\ 0\\.039251692957447445\ \(0\)\
\-\ \\,\\:\\ 0\\.03789940917242024\ \(0\)\
\-\ infectious\\:\\ 0\\.03673854867463838\ \(0\)\
\-\ cxr\\:\\ 0\\.03606032271125077\ \(0\)\
\-\ pa\\:\\ 0\\.035737714089068555\ \(0\)\
\-\ \\)\\:\\ 0\\.03567688460566525\ \(0\)\
\-\ above\\:\\ 0\\.03131938656627817\ \(0\)\
\-\ \\&\\:\\ 0\\.030013878921414317\ \(0\)\
\-\ vascular\\:\\ 0\\.028018032679236967\ \(0\)\
\-\ 5\\:\\ 0\\.025001604224441636\ \(0\)\
\-\ lung\\:\\ 0\\.02475159120238746\ \(0\)\
\-\ 4\\:\\ 0\\.023809719051790454\ \(0\)\
\-\ high\\:\\ 0\\.023385460610768155\ \(0\)\
\-\ \\:\\:\\ 0\\.0226054963198133\ \(0\)\
\-\ mild\\:\\ 0\\.02250253453931137\ \(0\)\
\-\ chest\\:\\ 0\\.020447290000575186\ \(0\)\
\-\ 1\\:\\ 0\\.02033326367959707\ \(0\)\
\-\ 3\\:\\ 0\\.020009755267065398\ \(0\)\
\-\ lateral\\:\\ 0\\.018466680456245502\ \(0\)\
\-\ 2\\:\\ 0\\.018401044965105463\ \(0\)\
\-\ presents\\:\\ 0\\.017456442955079258\ \(0\)\
\-\ disease\\:\\ 0\\.013967375412157042\ \(0\)\
\-\ as\\:\\ 0\\.012925775058941278\ \(0\)\
\-\ ct\\:\\ 0\\.011953036533920429\ \(0\)\
\-\ patient\\:\\ 0\\.00856591930916388\ \(0\)\
\-\ \\.\\:\\ 0\\.0021299721658407764\ \(0\)\
\-\ and\\:\\ 0\\.0018000900573221846\ \(0\)\
\-\ with\\:\\ 0\\.0011700417608988974\ \(0\)\
\-\ of\\:\\ 0\\.0011650380079798843\ \(0\)\
